Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of the Prophylactic Cerebral Radiotherapy in the Metastatic Breast Cancer Expressing HER2/NEU Treated by Trastuzumab

NCT01613482 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT01613482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01613482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of the Prophylactic Cerebral Radiotherapy in the Metastatic Breast Cancer Expressing HER2/NEU Treated by Trastuzumab
Lead sponsor
Centre Oscar Lambret
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2008
Completion date
January 31, 2012
Enrollment
13 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastasis, sur-expressing her2-neu